Jayne Crisman

Jayne Crisman is a Senior Analyst covering the Communication Services & Technology sector. Prior to joining Tech Insider in 2000, she worked at J.C. Bradford & Co. and Hoak Breedlove Wesneski & Co. covering wireless communications, and at Fidelity Investments before that. She is a five-time winner of the Wall Street Journal’s “Best on the Street” analysts survey, including ranking No. 1 in 2012 in the Telecommunications Equipment category.

After Hours Declines: Mindray Medical International (NYSE:MR), DXP Enterprises Inc. (NASDAQ:DXPE), Artisan Partners Asset Management Inc. (NYSE:APAM)

Mindray Medical International (NYSE:MR) is lower in after hours trading after the company reported financial results for Q4 that beat the single analyst estimate on Capital IQ and provided guidance for fiscal 2014. Shares are down 1.19% at $34.80, with a 52-week range of $33.88 – $43.81. The developer, manufacturer and marketer of medical devices…

Read More

Hot Stocks: Yingli Green Energy (NYSE:YGE), Trina Solar (NYSE:TSL), First Solar (NASDAQ:FSLR), LDK Solar (NYSE:LDK)

Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) has been moving steadily higher in 2014, with the shares up roughly 20%. Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) dropped -2.37% to $6.18 yesterday on volume of 1,100.00 shares. The intra-day range of the stock was $6.10 – $6.42. Yingli Green Energy Hold. Co. Ltd….

Read More

Pre-Market Movers: Dendreon (NASDAQ:DNDN), Arrowhead Research (NASDAQ:ARWR), Magna International Inc. (NYSE:MGA)

Shares of Dendreon (NASDAQ:DNDN) climbed in Monday’s pre-market session, after the biotechnology company reported a narrower-than-expected Q4 adjusted loss on revenue that was above Street estimates, and said it will make its Provenge prostate-cancer treatment commercially available in Germany and the U.K. Dendreon (NASDAQ:DNDN) was up 4.2% at $3 in recent pre-market trading. It has…

Read More

Biotech Overbought Stocks: Agenus Inc. (NASDAQ:AGEN), Biota Pharmaceuticals (NASDAQ:BOTA), Albany Molecular Research (NASDAQ:AMRI), Sunesis Pharmaceuticals (NASDAQ:SNSS)

Agenus Inc. (NASDAQ:AGEN) will release its fourth quarter and year end 2013 financial results before the market opens on March 5, 2014. Agenus Inc. (NASDAQ:AGEN) stock performance was 0.00% in last session and finished the day at $4.89. Traded volume was 0.00 shares in the last session and the average volume of the stock remained…

Read More